P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort

Kevin F. Deasy; Hisham Ibrahim; M. McCarthy; C. Fleming; J. Dorgan; C. Howlett; Yvonne Mccarthy; S. Twohig; P. O'Regan; Laura Kirwan; Desmond M. Murphy; Barry James Plant

doi:10.1016/s1569-1993(23)00617-3

P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort

Kevin F. Deasy
, Hisham Ibrahim
, M. McCarthy
, C. Fleming
, J. Dorgan
, C. Howlett
, Yvonne Mccarthy
, S. Twohig
, P. O'Regan
, Laura Kirwan
, Desmond M. Murphy
, Barry James Plant

Cork Centre for Cystic Fibrosis (3CF)
Cork University Hospital
Cystic Fibrosis Registry of Ireland
HRB Clinical Research Facility Cork

Research output: Contribution to journal › Meeting abstract › peer-review

Abstract

Microbiological analysis of patients-with-cystic-fibrosis (PWCF) is aided by spontaneous sputum expectoration at clinic visits.

Clinical trial and anecdotal real-world experience suggest this is changing post-ETI. We sought to characterise these changes in our centre.

Original language	English
Pages (from-to)	s140
Number of pages	1
Journal	Journal of Cystic Fibrosis
Volume	22
DOIs	https://doi.org/10.1016/s1569-1993(23)00617-3
Publication status	Published - Jun 2023
Externally published	Yes
Event	46th European Cystic Fibrosis Conference - Vienna, Austria Duration: 7 Jun 2023 → 10 Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Medicine
Sputum
Cystic fibrosis
Ivacaftor
Prospective cohort study
Internal medicine
Tuberculosis
Pathology
Cystic fibrosis transmembrane conductance regulator

Access to Document

10.1016/s1569-1993(23)00617-3Licence: Unspecified

Cite this

Deasy, K. F., Ibrahim, H., McCarthy, M., Fleming, C., Dorgan, J., Howlett, C., Mccarthy, Y., Twohig, S., O'Regan, P., Kirwan, L., Murphy, D. M., & Plant, B. J. (2023). P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort. Journal of Cystic Fibrosis, 22, s140. https://doi.org/10.1016/s1569-1993(23)00617-3

@article{5797ff46f702480c9d311aee9d7262ac,

title = "P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort",

abstract = "Microbiological analysis of patients-with-cystic-fibrosis (PWCF) is aided by spontaneous sputum expectoration at clinic visits. Clinical trial and anecdotal real-world experience suggest this is changing post-ETI. We sought to characterise these changes in our centre.",

keywords = "Medicine, Sputum, Cystic fibrosis, Ivacaftor, Prospective cohort study, Internal medicine, Tuberculosis, Pathology, Cystic fibrosis transmembrane conductance regulator",

author = "Deasy, \{Kevin F.\} and Hisham Ibrahim and M. McCarthy and C. Fleming and J. Dorgan and C. Howlett and Yvonne Mccarthy and S. Twohig and P. O'Regan and Laura Kirwan and Murphy, \{Desmond M.\} and Plant, \{Barry James\}",

year = "2023",

month = jun,

doi = "10.1016/s1569-1993(23)00617-3",

language = "English",

volume = "22",

pages = "s140",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

note = "46th European Cystic Fibrosis Conference ; Conference date: 07-06-2023 Through 10-06-2023",

}

Deasy, KF, Ibrahim, H, McCarthy, M, Fleming, C, Dorgan, J, Howlett, C, Mccarthy, Y, Twohig, S, O'Regan, P, Kirwan, L, Murphy, DM & Plant, BJ 2023, 'P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort', Journal of Cystic Fibrosis, vol. 22, pp. s140. https://doi.org/10.1016/s1569-1993(23)00617-3

TY - JOUR

T1 - P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort

AU - Deasy, Kevin F.

AU - Ibrahim, Hisham

AU - McCarthy, M.

AU - Fleming, C.

AU - Dorgan, J.

AU - Howlett, C.

AU - Mccarthy, Yvonne

AU - Twohig, S.

AU - O'Regan, P.

AU - Kirwan, Laura

AU - Murphy, Desmond M.

AU - Plant, Barry James

PY - 2023/6

Y1 - 2023/6

N2 - Microbiological analysis of patients-with-cystic-fibrosis (PWCF) is aided by spontaneous sputum expectoration at clinic visits. Clinical trial and anecdotal real-world experience suggest this is changing post-ETI. We sought to characterise these changes in our centre.

AB - Microbiological analysis of patients-with-cystic-fibrosis (PWCF) is aided by spontaneous sputum expectoration at clinic visits. Clinical trial and anecdotal real-world experience suggest this is changing post-ETI. We sought to characterise these changes in our centre.

KW - Medicine

KW - Sputum

KW - Cystic fibrosis

KW - Ivacaftor

KW - Prospective cohort study

KW - Internal medicine

KW - Tuberculosis

KW - Pathology

KW - Cystic fibrosis transmembrane conductance regulator

UR - https://openalex.org/W4379980612

U2 - 10.1016/s1569-1993(23)00617-3

DO - 10.1016/s1569-1993(23)00617-3

M3 - Meeting abstract

SN - 1569-1993

VL - 22

SP - s140

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

T2 - 46th European Cystic Fibrosis Conference

Y2 - 7 June 2023 through 10 June 2023

ER -

P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this